Tag: chronic low back pain

SynerFuse appoints Rohan Lall as chief medical officer

SynerFuse has announced the appointment of Rohan Lall (M Health Fairview Neurosurgery, Princeton, USA) as the company’s chief medical officer. The appointment was effective...

SynerFuse completes enrolment in proof-of-concept study

SynerFuse has announced that it has completed enrolment in its proof-of-concept study to evaluate the safety and tolerability of the Electric Transforaminal Lumbar Interbody...

Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition

Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...

First SynerFuse procedure performed by solo surgeon in two-level spinal fusion...

SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal...

Cochrane Library urged to retract and revise recent SCS review over...

Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low...

High-frequency spinal cord stimulation may be associated with “significant decrease” in...

High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs,...

SynerFuse announces “milestone” solo spine surgeon procedure in DRG stimulation study

Justin Zenanko, the CEO of SynerFuse, has announced that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse...

Non-pharmacological interventions more beneficial for patients with chronic low back pain...

For patients with chronic non-specific low back pain without radiculopathy, non-pharmacological interventions of acupuncture and spinal manipulation provide safer benefits than pharmacological or invasive...

Spatial distribution of fat infiltration within the paraspinal muscles a potentially...

Spatial distribution patterns of fat infiltration (FI) in the paraspinal muscles (PSMs) is a potential diagnostic biomarker that may also provide granular mechanistic insights...

Systemic problems rather than patient-physician relationship most likely reason for racial...

The disparities in chronic low back pain experienced by Black patients compared to White patients are not linked to the patient-physician relationship but are...

Meta-analysis highlights benefits of spinal manipulative therapy for older adults with...

Spinal manipulative therapy (SMT) is equally as effective as recommended interventions for reducing pain and increasing functional status in older adults who suffer chronic...

Initial use of spinal manipulative therapy reduces adverse drug event risk...

The use of spinal manipulative therapy (SMT) as initial treatment of chronic low back pain (cLBP) in older patients is associated with a substantial...
Patient-reported functional outcomes vary considerably after lumbar spinal fusion surgery

No clinical benefit in antibiotic use to treat low back pain

Three months of treatment with amoxicillin did not provide a clinically important benefit in patients with chronic low back pain and Modic changes, a...

Mainstay Medical to showcase ReActiv8 and key clinical data at the...

It has been announced that Mainstay Medical will participate in the upcoming 13th German Spine Congress of the Deutsche Wirbelsäulengesellschaft (DWG; 6—8 December, Wiesbaden,...

RTI Surgical announces HealthPartners’ positive coverage decision for minimally invasive sacroiliac...

RTI Surgical has announced that HealthPartners, the largest consumer governed non-profit healthcare organisation in the USA, issued a positive coverage decision for minimally invasive sacroiliac...

Therapeutic Goods Administration requests additional clinical data on Mainstay Medical’s ReActiv8

Mainstay Medical, a medical device company focused on bringing to market ReActiv8, an implantable restorative neurostimulation system to treat disabling chronic low back pain,...

SpinalCyte announces MRI evidence of disc regeneration following phase 1/phase 2...

MRI analysis of patients who received intradiscal injections of human dermal fibroblasts shows significant improvement in disc height after six months, the latest evidence...

State-of-the-art orthopaedic technique may help to identify which cervical radiculopathy patients...

  New research using unbiased serum proteomics, a state-of-the-art technique in orthopaedics, aims to predict which cervical radiculopathy patients will fail conservative treatment and consequently...
Patient-reported functional outcomes vary considerably after lumbar spinal fusion surgery

Radiofrequency denervation fails to provide clinically important chronic low back pain...

In three randomised trials, treatment of chronic low back pain (CLBP) with radiofrequency denervation resulted in either no improvement or no clinically important improvement...

Yoga as effective as physical therapy for chronic low back pain

Chronic low back pain affects approximately 10% of US adults and has a greater impact on racial or ethnic minorities and in people of...

ReActiv8’s clinically important disability, pain and quality-of-life improvements sustained at one-year

The disruption of lumbar multifidus muscle control is one factor involved in many cases of functional instability and chronic low back pain. Whilst targeted...